Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851758 · ClinicalTrials.gov registry record · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
A NA study of Extracorporeal Membrane Oxygenation Complication, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02851758: Recruiting NA study of Extracorporeal Membrane Oxygenation Complication, sponsored by Boston Children's Hospital.
NCT02851758 is a NA study of Extracorporeal Membrane Oxygenation Complication that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 16 participants, below the 836-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851758, a NA study of Extracorporeal Membrane Oxygenation Complication, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.
Primary Outcome
Subjects will be SAE free for one week following injection
Conditions Studied
Interventions
- OTHER autologous mitochondria transplantation
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT02851758 shows while recruiting
NCT02851758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 836-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Extracorporeal Membrane Oxygenation Complication appearing as the primary indexed condition, and to 1 intervention - of which autologous mitochondria transplantation is the first listed.
NCT02851758 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02851758 about?
NCT02851758 is a clinical study titled "Transplantation of Autologously Derived Mitochondria Following Ischemia". The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myoc...
What is the current status of trial NCT02851758?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2017-08-02. Estimated completion is 2027-06.
What conditions does trial NCT02851758 study?
This clinical trial studies the following conditions: Extracorporeal Membrane Oxygenation Complication.
What interventions are being tested in trial NCT02851758?
The interventions under investigation include: autologous mitochondria transplantation (OTHER).
Who is sponsoring clinical trial NCT02851758?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02851758 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Extracorporeal Membrane Oxygenation Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02851758's enrollment target sits among peer trials
16 8th of 8 higher than 1 of 8 other Extracorporeal Membrane Oxygenation Complication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Extracorporeal Membrane Oxygenation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platform of Randomized Adaptive Clinical Trials in Critical Illness
RECRUITING · NA
-
Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
-
The ECMO-Free Trial
ACTIVE NOT RECRUITING · NA
-
Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation
COMPLETED · NA
-
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- NCT03858751 · 16 participants · Phase 1
Pharmacological Activation of HMN for OSA Aim 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI